Home › Forums › News & Current Events › C.1.2 The new covid
- This topic has 11 replies, 6 voices, and was last updated 8 months, 2 weeks ago by
Canpreppergal.
-
AuthorPosts
-
-
August 30, 2021 at 7:17 am #39802
Matt In Oklahoma
ModeratorY’all ready for your 12th shot?
“I cannot wait for triple-vaxxers to be PISSED at the double-vaxxers”
-
August 30, 2021 at 9:06 am #39808
Crow Bar
KeymasterOh, brother.
-
August 30, 2021 at 12:32 pm #39823
Alaskan Mountain-Mama
ParticipantUgh
-
This reply was modified 8 months, 3 weeks ago by
Alaskan Mountain-Mama.
-
This reply was modified 8 months, 3 weeks ago by
-
August 30, 2021 at 4:48 pm #39832
Matt In Oklahoma
ModeratorLanguage warning but truth
-
September 1, 2021 at 2:33 pm #39882
Matt In Oklahoma
ModeratorUh oh it’s the new one the vaccine can’t touch
https://www.cnbc.com/2021/09/01/who-says-it-is-monitoring-a-new-covid-variant-called-mu.html
even though the vaccine isnt working very well on this variety
-
September 2, 2021 at 1:58 pm #39903
BarrensHomey
ParticipantEventually Bug Pharma will produce a vax so toxic that no amount of spin will excuse them. Will your daughter ever be capable of birthing a healthy child after Gates’ Vaxx95 iteration “accidentally” creates a generation of infertile citizens?
-
September 2, 2021 at 10:27 pm #39909
namelus
ParticipantNope they are going to make you take 2 pills a day plus the vaccine.
Pfizer Is Now Developing A Twice-Per-Day COVID Pill That Must Be Taken Alongside Vaccines
-
September 2, 2021 at 10:52 pm #39910
Matt In Oklahoma
ModeratorThe sound of crushing, lining and snorting in 3,2..
-
September 3, 2021 at 7:39 am #39912
Crow Bar
KeymasterAll for what? A bug that the average person has a 99.7% survival rate?
This is getting ridiculous. -
September 4, 2021 at 1:53 pm #39938
Canpreppergal
ParticipantNo wonder they are supressing all information regarding ambulatory treatments….They want ALL of the market!
-
-
September 3, 2021 at 8:36 am #39920
Matt In Oklahoma
Moderator
-
-
AuthorPosts
- You must be logged in to reply to this topic.